Evidence map›Paper›PMID 41393816›Full record

ReviewHeart views : the official journal of the Gulf Heart Association

Acute Coronary Syndrome in Essential Thrombocythemia and Polycythemia Vera.

Rasha Kaddoura, Dina Ahmed, Ahmed Rudwan, Ahmed Elyas, Mohamed A Yassin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heart views : the official journal of the Gulf Heart Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rasha KaddouraDepartment of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Dina AhmedAlexandria New Medical Center, Alexandria, Egypt.
Ahmed RudwanAcademic Health System, Medical Research Center, Hamad Medical Corporation, Doha, Qatar.
Ahmed ElyasDepartment of Cardiology, Heart Hospital, Hamad Medical Corporation, Doha, Qatar.
Mohamed A YassinDepartment of Hematology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essential thrombocythemia (ET) and polycythemia vera (PV) are rare chronic myeloproliferative neoplasms that have hemostatic complications (i.e., thrombosis and hemorrhage), leading to morbidity and mortality. Treatment in ET or PV is directed toward preventing thrombotic consequences. However, the increased risk of bleeding may complicate antithrombotic therapy in these patients. Thrombosis may occur in both arterial and venous vascular beds. Arterial thrombosis, such as acute coronary syndrome (ACS), is more frequent than venous thrombosis. Both ET and PV can initially present as an ACS, the management of which is highly challenging in the absence of clinical guidelines that are dedicated to such patients. The management of ACS in patients with ET or PV has not been well described in literature. Herein, this review discusses the pathogenesis, characteristics, and management of ACS in patients with ET or PV.

Indexed as

Antiplatelet therapyaspirinJanus kinase 2myeloproliferative neoplasmsmyocardial infarctionP2Y12 antagonistsplatelet activationplatelet aggregationprasugrelticagrelortoll-like receptors

Identifiers

PMID41393816
PMCPMC12697753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.